Introduction
Heart failure (HF) is characterized by an impaired ventricular filling and/or blood ejection caused by structural or functional cardiac dysfunction. It is recognized as a major and escalating public health problem. In the industrialized countries with aging population, around 2% of adults suffer from HF. Although some people survive many years, progressive disease is associated with an overall increased mortality and morbidity. Ho et al [1] showed in the Framingham study a 5-year mortality rate of 75% in men and of 62% in woman related to the initial diagnosis of chronic HF. An electronic nose (enose) is a technical instrument for determination of volatile compounds by using a sensor array [2] . Recent advances in enose technologies are based on many different electronic aroma detection principles and mechanism [3] . For this reason the application of such devices could be useful in food and pharmaceutical industry, environmental technology and in many fields of applied sciences to observe and qualify characteristic odors. In clinical studies enoses were applied for medical diagnosis and monitoring due to the fact that different diseases cause different effects on metabolism leading to distinctive human odors. Therefore, recent studies investigated whether noninvasive biomarkers of different diseases [4] might be determined with enoses. For the detection of volatile organic compounds (VOC) the measurements can be performed on breath [5] , sweat [6] or other excreta from humans [7] .
In a first study we could demonstrate the ability of an enose to detect HF from human skin surface. The discrimination between patients with HF and controls was successful in 85% [8] . Therefore, the objective of this study was to prove if the application of an enose system based on the analysis of volatile gases from exhaled breath might further improve the diagnostic precision in those patients.
Methods
Electronic nose: The applied enose system ( Fig.1 ) consists of a sensor module, controller module, data logger and data analysis system. The sensor module is based on a metal oxide gas sensor with three different sensitive layers. Each thin oxide layer has different sensitivities and selectivities for various gas molecules at different temperatures. The measuring principle is based on electrical conductivity changes caused by interactions between the gas molecules and the sensor layers. The controller unit controls the measurement and regulates the operating temperature between 200°C up to 400°C per measuring cycle. Each conductivity value at each different temperature is continuously recorded and amplified, by the controller module and finally stored on the data logger. The data logger contains a special software for data storing and configures the measurement procedure. Data analysis system is responsible for the extraction, classification and characterization of the sensor signals. Patients: The study population was recruited at the Clinic of Internal Medicine I of the Friedrich Schiller University Jena, Germany. The exhaled breath was examined in 13 patients with decompensated HF (DHF, mean age 72.62 ± 9.06), in 16 patients of compensated HF (CHF, mean age 75.81 ± 9.50) and in 13 controls without HF (CON, mean age 65.38 ± 9.61). A single exhaled breath was collected in a non-gassing, special sampling bag (500ml) which remained closed and is assembled with the sensor chip of the enose. For every patient 10 measurements over 35min were performed in the same air-conditioned room to avoid environmental influences.
Data Analysis: At first, data preprocessing was performed. The sensor signals were interpolated in relation to the temperature. Then a drift compensation was carried out on each averaged sensor curve. The three sensor signals were analyzed by using principal component analysis (PCA). This method reduces the multidimensional data space to its main components that are linear combinations of the sensor values and contain the maximum variance. For this the information from each complete sensor signal were reduced to the first and second components (POC -principal odor component) and are displayed in a score plot. The first component has the largest variance and the second component (with the next largest variance) is orthogonal to the first one. Finally, the discriminant function analysis (DFA) was applied as a statistical analysis technique for separating the odor components of the three groups.
Results
The results from the PCA analysis of the sensor signals were summarized for the first and second principal odor components (Fig. 2) . For the exhaled breath we achieved a classification rate of 91% between DHF and CHF, 97% between CON and CHF and finally 100% between CON and DHF.
Discussion
In this study the feasibility and the performance of an enose system to characterize the exhaled breath of patients with and without heart failure was demonstrated. The two groups of patients with different stages of HF (DHF and CHF) could be discriminated with an accuracy of 91%. Therefore, this approach seems to be suitable to monitor patients on an Intensive Care Unit (ICU). Here, it could, for example, be used for monitoring the therapy success. The discrimination rate between CON and CHF was 97%. Thus, this outstanding discrimination power could be useful for supporting the first-listed diagnosis of HF at general practitioners to reduce incorrect referrals (e.g. to the cardiologist). The discrimination between CON and DHF revealed the best result (100%), but is of less medical impact.
Limitations of this study were that the influences of ambient air, temperature of skin surface, medications, comorbidities and nutrition were not considered. Further on, the sensor signals from the enose system provide only changes of the sensor property but are not able to characterize the specific odor components. Therefore, gas chromatography in combination with mass spectrometry (GC/MS) have to be applied as reference method [9] . Furthermore, correlations with related clinical and biochemical parameters [6] should be taken into account. In conclusion, when applying an enose the measurement and analysis of exhaled breath improves the accuracy of HF diagnosis compared to the analysis of skin gas. Further on, after overcoming the above mentioned limitations such an enose system could provide a fast, non-invasive and low cost HF diagnostic tool.
